Yahoo Web Search

Search results

    • Merus (NASDAQ:MRUS) PT Raised to $93.00 at Guggenheim

      ETF DAILY NEWS· 5 hours ago

      The brokerage currently has a “buy” rating on the biotechnology company’s stock. Guggenheim’s target price would indicate a potential upside of 72.22% from the stock’s current ...